Ardent Health Partners (NYSE:ARDT) Now Covered by Analysts at Morgan Stanley

Morgan Stanley began coverage on shares of Ardent Health Partners (NYSE:ARDT) in a report released on Monday, MarketBeat reports. The brokerage issued an overweight rating and a $27.00 price target on the stock.

A number of other equities research analysts have also recently commented on ARDT. JPMorgan Chase & Co. began coverage on Ardent Health Partners in a report on Monday. They set a neutral rating and a $18.00 price target on the stock. SVB Leerink started coverage on shares of Ardent Health Partners in a report on Monday. They set an outperform rating and a $23.00 price objective for the company. Mizuho initiated coverage on shares of Ardent Health Partners in a research report on Monday. They set an outperform rating and a $20.00 target price for the company. Finally, Truist Financial started coverage on shares of Ardent Health Partners in a report on Monday. They issued a buy rating and a $21.00 price target on the stock. One analyst has rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of Buy and a consensus price target of $21.70.

Ardent Health Partners Trading Up 6.1 %

ARDT opened at $16.97 on Monday. Ardent Health Partners has a 1-year low of $15.00 and a 1-year high of $18.16.

About Ardent Health Partners

We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.